Back    Zoom +    Zoom -
CSPC PHARMA Announces Mgmt Overhaul
Recommend
9
Positive
24
Negative
9
CSPC PHARMA (01093.HK) announced that Zhang Cuilong has ceased to be the vice-chairman of the board, the CEO, and the authorized representative due to work reassignment, but will remain as an executive director.

Meanwhile, Cai Lei has been appointed as vice-chairman, an executive director, the CEO, and the authorized representative. Wei Qingjei has been appointed as vice-chairman, an executive director, and the COO.

Related NewsBofAS: CN Oct Drug Sales MoM Growth Significantly Slows; SINO BIOPHARM (01177.HK) TP Cut to $8.3

AAStocks Financial News